Repurposing ciclopirox as a pharmacological chaperone in a model of congenital erythropoietic porphyria.

MLA

Urquiza, Pedro, et al. “Repurposing Ciclopirox as a Pharmacological Chaperone in a Model of Congenital Erythropoietic Porphyria.” Science Translational Medicine, vol. 10, no. 459, Sept. 2018, p. 1–N.PAG. EBSCOhost, https://doi.org/10.1126/scitranslmed.aat7467.

APA

Urquiza, P., Laín, A., Sanz-Parra, A., Moreno, J., Bernardo-Seisdedos, G., Dubus, P., González, E., Gutiérrez-de-Juan, V., García, S., Eraña, H., San Juan, I., Macías, I., Ben Bdira, F., Pluta, P., Ortega, G., Oyarzábal, J., González-Muñiz, R., Rodríguez-Cuesta, J., Anguita, J., & Díez, E. (2018). Repurposing ciclopirox as a pharmacological chaperone in a model of congenital erythropoietic porphyria. Science Translational Medicine, 10(459), 1–N.PAG. https://doi.org/10.1126/scitranslmed.aat7467

Chicago

Urquiza, Pedro, Ana Laín, Arantza Sanz-Parra, Jorge Moreno, Ganeko Bernardo-Seisdedos, Pierre Dubus, Esperanza González, et al. 2018. “Repurposing Ciclopirox as a Pharmacological Chaperone in a Model of Congenital Erythropoietic Porphyria.” Science Translational Medicine 10 (459): 1–N.PAG. doi:10.1126/scitranslmed.aat7467.